MIR218-1: A Potential Drug Target and Biomarker (G407000)
MIR218-1: A Potential Drug Target and Biomarker
MIR218-1 (hsa-miR-218-5p) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is a member of the miRNA-218 family, which is known for its ability to regulate a wide range of cellular processes, including cell growth, differentiation, and survival.
MIR218-1 has been shown to play a role in several important cellular processes, including cell cycle progression, apoptosis, and tissue repair. It has been shown to promote the G1 phase of the cell cycle, which is important for cell growth and development, and has been shown to play a role in the regulation of cell apoptosis, which is the process by which cells die when they have reached their maximum number of copies and are no longer needed.
In addition to its role in cell biology, MIR218-1 has also been shown to have potential as a drug target. Several studies have shown that MIR218-1 can be targeted by small molecules, which have the potential to inhibit its activity. These studies have led to the development of a new class of drugs called microRNA inhibitors, which have been shown to have a wide range of therapeutic potential.
MIR218-1 has also been shown to be a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Its expression has been shown to be elevated in a variety of cancer types, including breast, ovarian, and colorectal cancer. It has also been shown to be expressed in the brains of individuals with neurodegenerative diseases, such as Alzheimer's and Parkinson's disease.
In conclusion, MIR218-1 is a non-coding RNA molecule that has been shown to play a role in a wide range of cellular processes, including cell cycle progression, apoptosis, and tissue repair. Its potential as a drug target or biomarker makes it an attractive target for further research and development. Further studies are needed to fully understand the role of MIR218-1 in cellular biology and its potential as a therapeutic agent.
Protein Name: MicroRNA 218-1
The "MIR218-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR218-1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR218-2 | MIR219A1 | MIR219A2 | MIR219B | MIR22 | MIR221 | MIR222 | MIR223 | MIR224 | MIR2276 | MIR2277 | MIR2278 | MIR22HG | MIR2355 | MIR2392 | MIR23A | MIR23AHG | MIR23B | MIR23C | MIR24-1 | MIR24-2 | MIR2467 | MIR25 | MIR2681 | MIR2682 | MIR26A1 | MIR26A2 | MIR26B | MIR27A | MIR27B | MIR28 | MIR2861 | MIR2909 | MIR296 | MIR297 | MIR298 | MIR299 | MIR29A | MIR29B1 | MIR29B2 | MIR29B2CHG | MIR29C | MIR300 | MIR301A | MIR301B | MIR302A | MIR302B | MIR302C | MIR302D | MIR302E | MIR302F | MIR3059 | MIR3064 | MIR3065 | MIR3074 | MIR3085 | MIR30A | MIR30B | MIR30C1 | MIR30C2 | MIR30D | MIR30E | MIR31 | MIR3115 | MIR3116-1 | MIR3116-2 | MIR3117 | MIR3118-1 | MIR3118-2 | MIR3118-3 | MIR3118-4 | MIR3118-5 | MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128 | MIR3129 | MIR3130-1 | MIR3130-2 | MIR3131 | MIR3132 | MIR3133 | MIR3134 | MIR3135A | MIR3135B | MIR3136 | MIR3137 | MIR3138 | MIR3139 | MIR3140 | MIR3141 | MIR3142
